ALPHAMED SCOTLAND LIMITED
Opportunity 72/100 (strong), bankability 75/100. High owner-dependency — earn-out structure likely required for clean transition. Share purchase looks the cleaner deal structure. Biggest value-creation lever: Broaden director team. Sole director creates succession risk and reduces buyer comfort. Appoint a second director or strong #2. Most likely exit: strategic trade sale (65/100).
Data confidence
Overall: medium (79/100)Adequate coverage. AI outputs are reliable for the sections scored high; verify the rest in diligence.
Solid opportunity signal. Worth a dedicated memo and management meeting.
Signals from accounts
Derived from iXBRL accounts · FRS 105 (micro)Key financials
2 years extracted from filed iXBRL accountsHover to see exact values · click legend to toggle series
Financials
Extracted from Companies House accounts · FRS 105 (micro)| Metric | 2025-04-30 | 2024-04-30 |
|---|---|---|
| Total assets | £277.7k | £185.7k |
| Current assets | £239.1k | £165.9k |
| Net assets | £256.1k | £164.3k |
Amounts extracted automatically from iXBRL. Fields left blank were not reported or not mapped. Values in GBP unless stated.
1 signal detected in this company's narrative notes — going-concern language, audit opinion, contingent liabilities, related-party transactions.
Available from the Pro tier upwards.
See pricing →Recent activity
- • 1 accounts
Corporate timeline (16 events)Click to expand
- 2026-01-05📄accounts-with-accounts-type-micro-entityaccounts · AA
- 2025-04-23📄notification-of-a-person-with-significant-controlpersons-with-significant-control · PSC02
- 2025-04-22📄change-to-a-person-with-significant-controlpersons-with-significant-control · PSC04
- 2025-04-14📄capital-cancellation-sharescapital · SH06
- 2025-02-28📄capital-name-of-class-of-sharescapital · SH08
- 2025-02-25📄accounts-with-accounts-type-micro-entityaccounts · AA
- 2024-04-29📄accounts-with-accounts-type-micro-entityaccounts · AA
- 2022-11-08📄accounts-with-accounts-type-micro-entityaccounts · AA
- 2022-05-09📄change-account-reference-date-company-previous-extendedaccounts · AA01
- 2021-06-11📄cessation-of-a-person-with-significant-controlpersons-with-significant-control · PSC07
- 2021-05-05📄termination-director-company-with-name-termination-dateofficers · TM01
- 2021-05-04➖LYON, Richard Mark, Dr resigneddirector
- 2021-02-10🏢Company incorporatedAs ALPHAMED SCOTLAND LIMITED
- 2021-02-10➕RICHARDSON, Sarah Elizabeth, Dr appointeddirector
- 2021-02-10➕LYON, Richard Mark, Dr appointeddirector
- 2021-02-10📄incorporation-companyincorporation · NEWINC
Owner dependency
Material founder dependency. Consider a 2-3 year earn-out and build in a handover plan before completion.
- +Sole director: Only one active director — all governance concentrated on one person.
Succession & seller-readiness
Some succession indicators present. Worth watching; approach if sector/strategy fits.
- primarySole active director: Only one director in control. No visible successor — buyers solve the succession problem.
Red flags
cleanGroup structure
Lionheart (Europe) Ltd holds 25-50% — a significant corporate investor but not a controlling parent.
Parent relationships inferred from Persons with Significant Control filings. Full subsidiary tree requires reverse-lookup (coming).
Shareholders & ownership
2 active beneficial owners| Name | Shares | Voting rights | Nature of control | Notified |
|---|---|---|---|---|
Lionheart (Europe) Ltd Corporate entity | 25–50% | 25–50% | 25-50% shares · 25-50% voting | 01/01/2025 |
Dr Sarah Elizabeth Richardson Individual · British · DOB 08/1988 · age 38 | 25–50% | 25–50% | 25-50% shares · 25-50% voting | 10/02/2021 |
1 historic (ceased) PSC
- Dr Richard Mark Lyonceased 01/04/2021· 25-50% shares
From Companies House Persons with Significant Control filings. Share ranges are banded per the public PSC regime.
Radial SVG graph showing every company connected via shared directors, colour-coded by status.
Available from the Pro tier upwards.
See pricing →Similar companies
Active · Healthcare & medical · EH postcode area| Company | Est. value | Turnover | Net worth | Staff | Age | Opp | Director |
|---|---|---|---|---|---|---|---|
| AVODAH CARE LTD→ SC726265 · est 2022 · no financials extracted | — | — | — | — | 4y | — | — |
| BALLANTINE GOLDIE LTD→ SC392228 · est 2011 · no financials extracted | — | — | — | — | 15y | — | — |
| BLETHER SOCIAL LIMITED→ SC836308 · est 2025 · no financials extracted | — | — | — | — | 1y | — | — |
| BLUE-STREAM HEALTH LIMITED→ SC873150 · est 2025 · no financials extracted | — | — | — | — | — | — | — |
| BM ORTHOWORX LTD→ SC396942 · est 2011 · no financials extracted | — | — | — | — | 15y | — | — |
| BOLD - BRINGING OUT LEADERS IN DEMENTIA C.I.C.→ SC821079 · est 2024 · no financials extracted | — | — | — | — | 1y | — | — |
| BONNYRIGGDC LTD→ SC878781 · est 2026 · no financials extracted | — | — | — | — | — | — | — |
| BORDERS PSYCHOLOGICAL SERVICES LTD→ SC868692 · est 2025 · no financials extracted | — | — | — | — | — | — | — |
| BREATHPOD LTD→ SC577790 · est 2017 · no financials extracted | — | — | — | — | 8y | — | — |
| BREEZE PSYCHOLOGICAL SERVICES LTD→ SC880717 · est 2026 · no financials extracted | — | — | — | — | — | — | — |
| BRUSH IMAGING LIMITED→ SC393307 · est 2011 · no financials extracted | — | — | — | — | 15y | — | — |
| BRVTH LTD→ SC775102 · est 2023 · no financials extracted | — | — | — | — | 2y | — | — |
7 specific questions generated from this company's actual signals — liquidity, leverage, director age, charge count, red flags, age-of-company.
Available from the Pro tier upwards.
See pricing →Exit-route ranking, improvement thesis, quiet-distress detector, covenant-pressure proxy, extraction monitor, approaching triggers, ownership drift, local cluster, value trap, debt capacity, archetype classification — 48+ scoring modules.
Available from the Pro tier upwards.
See pricing →Company details
Registered office
Filing status
Officers (1 active · 1 resigned)
Click a director name to see their full track record across all companies.